Ultragenyx Pharmaceutical, Inc. (RARE)

23.38 +0.08 (+0.34%) USD  |  NASDAQ  |  Apr 13, 12:05
More

Ultragenyx Pharmaceutical Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Xencor, Inc. Upgrade